• Actavis Inc., of Parsippany, N.J., and Valeant Pharmaceuticals International Inc., of Montreal, said Actavis Specialty Brands has acquired worldwide rights to Valeant's metronidazole 1.3 percent vaginal gel antibiotic, a topical antibiotic for the treatment of bacterial vaginosis.